Is parenteral methotrexate worth trying?
- 1 April 2001
- journal article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 60 (4) , 432
- https://doi.org/10.1136/ard.60.4.432
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trialThe Lancet, 1999
- Treatment of Active Rheumatoid Arthritis With Leflunomide Compared With Placebo and MethotrexateArchives of internal medicine (1960), 1999
- The population pharmacokinetics of long‐term methotrexate in rheumatoid arthritisBritish Journal of Clinical Pharmacology, 1998
- METHOTREXATE USE IN RHEUMATOID ARTHRITISRheumatic Disease Clinics of North America, 1997
- Comparison of intramuscular methotrexate and gold sodium thiomalate in the treatment of early erosive rheumatoid arthritis: 12 month data of a double-blind parallel study of 174 patientsRheumatology, 1997
- Why intramuscular methotrexate may be more efficacious than oral dosing in patients with rheumatoid arthritisRheumatology, 1997